Biden Appoints CIRM board member Ysabel Duron to National Cancer Advisory Board

/

President Biden appointed Ysabel Duron, the award-winning journalist, patient advocate, cancer survivor and board member of the California Institute for Regenerative Medicine (CIRM), to the National Cancer Advisory Board.

Vital role

The board plays a key role in guiding the national cancer research program and will complement the Cancer Moonshot initiative, which President Biden reignited last year. The Moonshot invests in research and development aimed at advancing breakthroughs to prevent, detect, and treat diseases like cancer.

“As a Latina and a long‑time patient and community advocate, I’m humbled to join this roster of stellar appointees,” Duron said. “I look forward to amplifying the voices of racial and ethnic communities and other vulnerable populations.”

Cancer survivor

Duron came into the cancer space after her own bout with Hodgkins Lymphoma in 1999. She covered her own cancer battle using her reporting skills to raise awareness about the disease.  

Over time, she highlighted the many disparities she saw. The limited access, income inequality, language barriers, and other social determinants of health that intensified the disproportionate cancer burden in Latino communities

Latino Cancer Institute

In 2017, Ms. Duron founded The Latino Cancer Institute (TLCI). TLCI is a nationwide network that develops and shares best‑practice programs to strengthen Latino community service agencies. It does this by collaborating with the global cancer research community, and drives policy to address the burden of Latinx/Hispanic cancer.

Duron also serves on the Institutional Review Board for the NIH All of Us Research Program. She also recently joined the newly launched American Cancer Society National Breast Cancer Roundtable.

Read the official White House press release here. 

Journalism Pioneer and Founder of the Latino Cancer Institute Joins CIRM Board

Dr. Deborah Deas and Ysabel Duron Recognized for their Work in Public Health

Thirteen Organizations Issue Joint Patient Advisory on Unproven Stem Cell Therapies

Leave a Reply